VanEck Withdraws stETH ETF Application a Year After Filing

cryptonews.ruPublished on 2026-10-16Last updated on 2026-10-16

Abstract

VanEck has withdrawn its registration statement for the VanEck Lido Staked Ethereum ETF. The application was originally filed with the U.S. Securities and Exchange Commission (SEC) on October 16, 2025, and was officially pulled via a Rule 477 request on October 14, 2026. In the filing, VanEck stated it "does not intend to proceed with the trust's planned securities offering." The firm has not disclosed its reasons for the withdrawal and has not announced a replacement fund. It remains unclear whether VanEck plans to propose a different investment product based on Lido's stETH token in the future.

VanEck has withdrawn the registration statement for the VanEck Lido Staked Ethereum ETF, which was filed with the U.S. Securities and Exchange Commission (SEC) back on October 16, 2025.

The company submitted the request on October 14, 2026, under Rule 477 of the Securities Act of 1933. The document states that the issuer "does not intend to proceed with the planned distribution of trust shares." The reasons for the decision were not disclosed, no replacement fund was announced, and it is unknown whether VanEck will return with another product based on Lido.

Related Questions

QWhat did VanEck officially withdraw according to the article?

AVanEck withdrew its registration statement for the VanEck Lido Staked Ethereum ETF, which was filed with the U.S. Securities and Exchange Commission (SEC).

QWhen was the VanEck Lido Staked Ethereum ETF application originally filed with the SEC?

AIt was originally filed with the SEC on October 16, 2025.

QOn what date in 2026 did VanEck request the withdrawal of its ETF registration?

AVanEck requested the withdrawal on October 14, 2026.

QUnder which specific rule did VanEck file its withdrawal request?

AThe withdrawal request was filed under Rule 477 of the Securities Act of 1933.

QWhat reason did VanEck give for withdrawing the ETF, and are any alternative plans mentioned?

AThe article states that the issuer has 'no intention to proceed with the Trust's shares distribution' at this time. The reasons are not disclosed, no replacement fund was announced, and it is unknown if VanEck will return with another Lido-based product.

Related Reads

How Various Assets Have Performed So Far This Year: Bitcoin at -22% Return, Dead Last

As of November 13, 2026, Bitcoin has posted a -22.0% year-to-date return, ranking last among major asset classes. In contrast, the Philadelphia Semiconductor Index gained 43.2% despite a sharp pullback from its mid-year peak of 106.6%, while the S&P 500 and Nasdaq Composite held steady gains of roughly 8% to 10%. Even the CSI 300 (-13.3%) and gold GLD (-10.3%) outperformed Bitcoin. The article argues the key difference lies in the presence of real buying support. Semiconductors are backed by massive capital expenditure and order backlogs from major tech companies, giving them an earnings floor even after steep corrections. Bitcoin, by contrast, lacks such support. After spot ETFs helped Wall Street finish building core positions in 2024–2025, 2026 brought neither broad macro liquidity nor a new narrative capable of drawing fresh capital. ETF inflows slowed from a flood to a seasonal trickle. Without sustained new buyers, Bitcoin's high beta works only to the downside: in a stock-picking, zero-sum market it becomes the asset everyone wants to sell into strength. The article further notes that Bitcoin's positioning is losing focus. It has failed to act as either a "digital gold" hedge or a high-beta proxy for tech stocks. It lagged the Nasdaq and S&P 500 during the tech rally, and fell harder than gold when global assets contracted in November. The conclusion: Wall Street treats Bitcoin not as a safe haven but as a highly liquid, 24/7 liquidation tool—the first asset sold when institutions need to meet margin calls or lock in yearly profits. Crypto has been admitted to the table, but often as the one picked to pay the bill.

marsbit11m ago

How Various Assets Have Performed So Far This Year: Bitcoin at -22% Return, Dead Last

marsbit11m ago

From QR Codes to Physical Goods: How Consumer RWA Verifies Products and Rights

A single QR code can be printed on two bottles and scanned twice to open the same page, so verifying a physical item requires confirming the binding between the bottle in hand and its listed number. Consumer RWA verification has two parts: whether the goods or services are real, and whether the rights recorded in the digital credential are valid. For rights provenance, take a co-branded gift box: authorization documents define the term and scope in which a brand may use the co-branded mark, production and warehousing records show whether the box was stocked by batch, and rights registration states what holders can redeem and who delivers it. Linking all three lets consumers check authorization scope, supply, and their own eligibility. Identifiers, events, and evidence must work together. High-value items can use unique serial numbers, uniform-spec goods can use batch numbers, and courses or events can use session numbers. Events such as warehousing, sampling, outbound shipment, receipt, and redemption should be tied to the corresponding object, with operation time and responsible party retained. Test reports correspond to submitted samples; linking results to specific goods also requires checking the sample, batch, and inbound/outbound records. Ordinary batch goods can combine serialized QR codes with abnormal-scan records, while high-value items may add tamper-evident labels or independent authentication. Trusted records must also reflect current status. If a coffee batch has 500 bags at warehousing, 10 used for sampling, and 100 reserved for other channels, then absent other changes, 390 bags remain available for new rights. The warehousing record shows historical quantity; current redeemable quantity must be updated based on actual occupancy. A query page should at minimum state the goods or service, evidence source, last update time, and whether the credential is currently usable.

marsbit47m ago

From QR Codes to Physical Goods: How Consumer RWA Verifies Products and Rights

marsbit47m ago

10 Years Is Too Slow: Gu Quanquan's Team Challenges Dario, Compressing Cancer Cure to 4 Years

A UCLA professor, Quanquan Gu, has founded Geodesic Intelligence, a 15-person startup that after only five months has released NovaAtom-Lite, an all-atom structure prediction model that outperforms DeepMind's Isomorphic Labs flagship IsoDDE on FoldBench, the toughest biomolecular benchmark. The model predicts the 3D coordinates of every heavy atom in protein, DNA, RNA, and ligand complexes with near-experimental precision. NovaAtom-Lite posted top scores on two core pharma tests: antibody-antigen binding (79.07% success, 31 points above AlphaFold 3 and 3.5 above IsoDDE, with 2.2x AlphaFold 3's accuracy at high-precision thresholds) and protein-ligand binding (top 1 on both RMSD and contact metrics). On the Runs N' Poses benchmark, which separates memorization from genuine physics understanding, NovaAtom-Lite's lead grows on the most novel, out-of-distribution ligands (47.6% vs AlphaFold 3's 24%), showing it learns transferable physical rules rather than memorizing structures. The model also supports test-time scaling—raising sampling from 1 to 100 seeds lifts antibody success from 74.3% to 83.1%—and condition constraints, where a single contact-pair hint boosts success to 91.28% and full pocket hints lift hard-case ligand accuracy by nearly 16 points. It solved two nightmare cases: a wildly flexible 22-residue MERS nanobody loop (0.56 Å error, all 25 samples correct) and the KRAS G13D hidden switch-II pocket (0.98 Å ligand RMSD vs OpenDDE's 17.74 Å). Gu previously led ByteDance's SeedFold, the first model to beat AlphaFold 3 on FoldBench, forcing Isomorphic Labs to respond with IsoDDE. A stronger NovaAtom-Pro is coming. Days after launch, a16z cited NovaAtom-Lite in a report arguing pharma is entering its "GPT-3 moment," naming Geodesic as the sole company highlighted in its industry map. Geodesic's closed loop spans structure prediction, scientific reasoning, and wet-lab validation—aiming to compress drug discovery from a decade to four years.

marsbit1h ago

10 Years Is Too Slow: Gu Quanquan's Team Challenges Dario, Compressing Cancer Cure to 4 Years

marsbit1h ago

Trading

Spot
活动图片